Clinical Trials Directory

Trials / Completed

CompletedNCT06370403

Effects of Head and Neck Cooling and Heating on Fatigue in Multiple Sclerosis and Healthy Men

Effects of Head and Neck Cooling and Heating on Central and Peripheral Fatigue, Motor Accuracy and Blood Markers of Stress in Multiple Sclerosis and Healthy Men

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Lithuanian Sports University · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Local head and neck cooling strategies can help reduce multiple sclerosis-related fatigue, while heating can exacerbate heat-related fatigue. However, no study has detailed the peripheral and central responses to head and neck cooling (at 18°C) and heating (at 43 ± 1°C next to the scalp and neck skin) during fatiguing isometric exercise in non-challenging ambient temperature in multiple sclerosis and healthy male subjects. In addition, there is a lack of data describing the effects of head and neck cooling/heating and strenuous exercise on blood markers, muscle temperature, motor accuracy, and rate of perceived exertion. The investigators hypothesized that: (i) men with multiple sclerosis would be more affected by central and peripheral fatigue compared to healthy subjects; (ii) local cooling will result in greater central fatigue but will be associated with greater peripheral fatigue, whereas heating will result in greater central and peripheral fatigue in multiple sclerosis men; (iv) local cooling and heating will have a greater effect on the release of stress hormones, rate of perceived exertion and motor accuracy compared to the control condition in both multiple sclerosis and healthy groups.

Conditions

Interventions

TypeNameDescription
OTHERCooling of the head and neckCooling of the head and neck at 18°C next to the head and neck skin in multiple sclerosis and healthy subjects
OTHERHeating of the head and neckHeating of the head and neck at 43 ± 1°C next to the head and neck skin in multiple sclerosis

Timeline

Start date
2014-02-04
Primary completion
2016-03-01
Completion
2017-01-08
First posted
2024-04-17
Last updated
2024-04-19

Locations

1 site across 1 country: Lithuania

Source: ClinicalTrials.gov record NCT06370403. Inclusion in this directory is not an endorsement.